CryoPort (NASDAQ:CYRX) announced its quarterly earnings data on Thursday. The consumer goods maker reported ($0.09) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02), Briefing.com reports. The business had revenue of $4.63 million during the quarter, compared to analysts’ expectations of $4.36 million. CryoPort had a negative return on equity of 48.12% and a negative net margin of 66.29%. The business’s revenue was up 58.6% compared to the same quarter last year.

Shares of NASDAQ CYRX traded down $0.81 during midday trading on Friday, hitting $15.26. The stock had a trading volume of 1,378,169 shares, compared to its average volume of 254,733. The company has a market cap of $426.76 million, a PE ratio of -44.88 and a beta of 0.85. CryoPort has a 52 week low of $6.02 and a 52 week high of $16.88.

CYRX has been the topic of a number of recent research reports. ValuEngine upgraded shares of CryoPort from a “buy” rating to a “strong-buy” rating in a report on Wednesday, May 2nd. BidaskClub upgraded shares of CryoPort from a “hold” rating to a “buy” rating in a report on Monday, May 14th. Roth Capital upped their price objective on shares of CryoPort from $12.50 to $22.00 and gave the stock a “buy” rating in a report on Friday, June 29th. Finally, Needham & Company LLC upped their price objective on shares of CryoPort from $11.00 to $19.00 and gave the stock a “buy” rating in a report on Monday, July 2nd. Five investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $16.00.

In other news, CEO Jerrell Shelton sold 2,252 shares of the company’s stock in a transaction that occurred on Tuesday, June 12th. The shares were sold at an average price of $13.06, for a total value of $29,411.12. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 9.60% of the company’s stock.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Further Reading: Google Finance Portfolio Workaround

Earnings History for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.